Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70525 ↗At a glance
Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2026. Written by Yuki Utakata and 10 co-authors. Institution: Department of Gastroenterology, Chuno Kosei Hospital, Seki, Japan. Major MEDLINE topics: Liver Cirrhosis, Amino Acids, Branched-Chain, Tyrosine. Cited 9 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Japan Society for the Promotion of Science.
Abstract (original language)
Background
Amino acid imbalance, characterised by decreased branched‐chain amino acids (BCAAs) and increased tyrosine levels, is a common metabolic disturbance associated with various complications in patients with cirrhosis. However, the independent prognostic value of these changes remains unclear.
Aims
This study aimed to elucidate the prognostic impact of amino acid imbalance by analysing BCAA and tyrosine levels in patients with cirrhosis.
Methods
This multicenter retrospective study reviewed patients hospitalised for cirrhosis in Gifu, Japan. Amino acid imbalance was evaluated using serum BCAA and tyrosine levels and the BCAA‐to‐tyrosine ratio (BTR). Prognosis was assessed using a Cox proportional hazards regression model. Multivariable analyses were conducted using a model that included BTR, which was then replaced with both BCAA and tyrosine levels.
Results
Amongst 541 patients (median age, 66 years; 50.3% female), 129 (23.8%) died during a median follow‐up of 3.5 years. The median BTR, serum BCAA and tyrosine levels were 4.36, 378 and 90 μmol/L, respectively. Multivariable analysis identified BTR (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.72–0.94; p = 0.004) as a significant prognostic factor after adjustment for established factors. In the subsequent model, both BCAA (HR, 1.00; 95% CI, 1.00–1.00; p = 0.019) and tyrosine levels (HR, 1.01; 95% CI, 1.00–1.01; p = 0.002) independently predicted mortality.
Conclusions
Amino acid imbalance is an independent factor for poor prognosis in patients with cirrhosis. Notably, decreased BCAA and increased tyrosine levels were identified as independent prognostic factors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, Chuno Kosei Hospital, Seki, Japan.
- Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
- Department of Medicine, University of California San Diego, La Jolla, California, USA.
ORCID profiles: Yuki Utakata, Takao Miwa, Shinji Unome, Naoya Masuda, Masashi Aiba, Kenji Imai, Masahito Shimizu
Funding
- Japan Society for the Promotion of Science
Cite
APA
Utakata, Y., Miwa, T., Unome, S., Masuda, N., Oi, M., Aiba, M., Imai, K., Takai, K., Shiraki, M., Katsumura, N., & Shimizu, M. (2026). Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70525
Vancouver
Utakata Y, Miwa T, Unome S, Masuda N, Oi M, Aiba M, et al. Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70525
BibTeX
@article{Utakata2026,
author = {Utakata, Yuki and Miwa, Takao and Unome, Shinji and Masuda, Naoya and Oi, Mikita and Aiba, Masashi and Imai, Kenji and Takai, Koji and Shiraki, Makoto and Katsumura, Naoki and Shimizu, Masahito},
title = {Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70525}
}
EUVIMED